Phenylephrine bitartrate
Pro Research Analysisby 
Searched over 200M research papers for "phenylephrine bitartrate"
Phenylephrine Bitartrate: Stability, Efficacy, and Pharmacological Insights
Stability of Phenylephrine Bitartrate
Degradation Under Irradiation
Phenylephrine bitartrate, a commonly used sympathomimetic drug, has been studied for its stability under various conditions. Research using electrospray ionisation-mass spectrometry has shown that phenylephrine bitartrate is prone to degradation when exposed to solar radiation. The primary degradation product identified is a phenylephrine derivative with an unsaturated side chain, formed by the loss of a water molecule. This degradation is more pronounced in phenylephrine bitartrate compared to phenylephrine hydrochloride, likely due to the additional decomposition sensitivity of the tartaric acid counter ion .
Degradation Products
Further analysis revealed multiple degradation and oxidation products, indicating the overall low stability of phenylephrine bitartrate. The interaction between phenylephrine and its counter ion degradation products via a nucleophilic addition mechanism is suggested as a contributing factor to the observed degradation .
Efficacy and Safety of Phenylephrine Bitartrate
FDA Approval for OTC Use
The FDA has recognized phenylephrine bitartrate as generally safe and effective (GRASE) for over-the-counter (OTC) use in nasal decongestant drug products. This approval includes both individual and combination drug products in an effervescent dosage form, which is intended to be dissolved in water before oral administration. This decision is part of the FDA's ongoing review of OTC drug products to ensure their safety and efficacy for consumer use .
Pharmacological Insights
Comparison with Clonidine
Phenylephrine, a selective α1-adrenoceptor agonist, has been shown to be a potent excitant of cortical neurons. Comparative studies with clonidine, a relatively selective α2-adrenoceptor agonist, indicate that phenylephrine is significantly more potent. In experiments involving the somatosensory cortex of anesthetized rats, phenylephrine consistently elicited excitatory responses in neurons, whereas clonidine showed much weaker agonistic activity. Furthermore, clonidine was found to antagonize the excitatory responses to phenylephrine and noradrenaline, but not to acetylcholine, suggesting a specific interaction at α1-adrenoceptors .
Conclusion
Phenylephrine bitartrate is a widely used sympathomimetic drug with recognized efficacy and safety for OTC use as a nasal decongestant. However, it exhibits low stability under irradiation, leading to significant degradation. Pharmacologically, phenylephrine is a potent α1-adrenoceptor agonist, with a much stronger excitatory effect on cortical neurons compared to clonidine. These insights are crucial for both clinical applications and further research into the stability and efficacy of phenylephrine bitartrate.
Sources and full results
Most relevant research papers on this topic